Skip to main content
HSTC
OTC Life Sciences

President and Interim CFO Michael Field Acquires 43.4M Shares in Rights Offering, Boosting Stake to 31%

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$0.7
Mkt Cap
$99.002M
52W Low
$0
52W High
$1.15
52W Position
Off High info
39% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HSTC filed a Ownership and Investor Activity on light trading volume (0.1× avg).

Summary

President and Interim CFO Michael Field acquired 43.4 million shares of HST Global for $156,389.66 in a rights offering, increasing his total stake to 86.9 million shares (31% of the company). The purchase was funded with personal funds and debt conversion.


Key Events · Ownership and Investor Activity · HSTC

  • Insider Acquires 43.4M Shares

    President and Interim CFO Michael Field purchased 43,441,573 shares for $156,389.66 in a shareholder rights offering, increasing his total holdings to 86,883,146 shares.

  • Stake Rises to 31%

    Following the acquisition, Field beneficially owns 31% of HST Global's common stock, reinforcing his significant ownership position.

  • Funding from Personal Resources

    The purchase was funded with $156,389.66 from personal funds, including cash and conversion of indebtedness, demonstrating personal financial commitment.

  • Rights Offering Structure

    The transaction was a 1-for-1 rights purchase that did not change Field's percentage ownership, indicating proportional participation in the offering.


Analysis · HSTC · Life Sciences

A $156,389.66 personal commitment from President and Interim CFO Michael Field signals strong confidence in HST Global's future. Through a shareholder rights offering, he acquired 43.4 million shares, lifting his total holdings to 86.9 million shares, or 31% of the company. The purchase was funded with personal cash and debt conversion. Although the 1-for-1 structure left his percentage ownership unchanged, the substantial dollar outlay underscores a meaningful alignment of management and shareholder interests.

At the time of this filing, HSTC was trading at $0.70 on OTC in the Life Sciences sector, with a market capitalization of approximately $99M. The 52-week trading range was $0.00 to $1.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSTC - Latest Insights